Clinical Trials Insight: 700027648
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2008
At a glance
- Drugs Sodium stibogluconate (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics
- Sponsors VioQuest Pharmaceuticals
- 01 Apr 2008 Results will be presented at the 44th ASCO in June 2008, according to a VioQuest media release.
- 15 Oct 2007 Interim results have been reported.
- 15 Oct 2007 New trial record.